Across TCGA pan-cancer cohorts, GOLGA8IP RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated GOLGA8IP data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GOLGA8IP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA8IP expression acts as an unfavorable survival marker, although some lineages such as SARC and LAML show a favorable association.
UCEC, KIRC, and LUSC are the cancer types where GOLGA8IP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.